Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ponatinib market report explains the definition, types, applications, major countries, and major players of the Ponatinib market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
ARIAD Pharmaceuticals
By Type:
45mg
15mg
By End-User:
CML
ALL
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Ponatinib Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Ponatinib Outlook to 2028- Original Forecasts
-
2.2 Ponatinib Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Ponatinib Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Ponatinib Market- Recent Developments
-
6.1 Ponatinib Market News and Developments
-
6.2 Ponatinib Market Deals Landscape
7 Ponatinib Raw Materials and Cost Structure Analysis
-
7.1 Ponatinib Key Raw Materials
-
7.2 Ponatinib Price Trend of Key Raw Materials
-
7.3 Ponatinib Key Suppliers of Raw Materials
-
7.4 Ponatinib Market Concentration Rate of Raw Materials
-
7.5 Ponatinib Cost Structure Analysis
-
7.5.1 Ponatinib Raw Materials Analysis
-
7.5.2 Ponatinib Labor Cost Analysis
-
7.5.3 Ponatinib Manufacturing Expenses Analysis
8 Global Ponatinib Import and Export Analysis (Top 10 Countries)
-
8.1 Global Ponatinib Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Ponatinib Export by Region (Top 10 Countries) (2017-2028)
9 Global Ponatinib Market Outlook by Types and Applications to 2022
-
9.1 Global Ponatinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 45mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 15mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Ponatinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global CML Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ALL Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Ponatinib Market Analysis and Outlook till 2022
-
10.1 Global Ponatinib Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Ponatinib Consumption (2017-2022)
-
10.2.2 Canada Ponatinib Consumption (2017-2022)
-
10.2.3 Mexico Ponatinib Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Ponatinib Consumption (2017-2022)
-
10.3.2 UK Ponatinib Consumption (2017-2022)
-
10.3.3 Spain Ponatinib Consumption (2017-2022)
-
10.3.4 Belgium Ponatinib Consumption (2017-2022)
-
10.3.5 France Ponatinib Consumption (2017-2022)
-
10.3.6 Italy Ponatinib Consumption (2017-2022)
-
10.3.7 Denmark Ponatinib Consumption (2017-2022)
-
10.3.8 Finland Ponatinib Consumption (2017-2022)
-
10.3.9 Norway Ponatinib Consumption (2017-2022)
-
10.3.10 Sweden Ponatinib Consumption (2017-2022)
-
10.3.11 Poland Ponatinib Consumption (2017-2022)
-
10.3.12 Russia Ponatinib Consumption (2017-2022)
-
10.3.13 Turkey Ponatinib Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Ponatinib Consumption (2017-2022)
-
10.4.2 Japan Ponatinib Consumption (2017-2022)
-
10.4.3 India Ponatinib Consumption (2017-2022)
-
10.4.4 South Korea Ponatinib Consumption (2017-2022)
-
10.4.5 Pakistan Ponatinib Consumption (2017-2022)
-
10.4.6 Bangladesh Ponatinib Consumption (2017-2022)
-
10.4.7 Indonesia Ponatinib Consumption (2017-2022)
-
10.4.8 Thailand Ponatinib Consumption (2017-2022)
-
10.4.9 Singapore Ponatinib Consumption (2017-2022)
-
10.4.10 Malaysia Ponatinib Consumption (2017-2022)
-
10.4.11 Philippines Ponatinib Consumption (2017-2022)
-
10.4.12 Vietnam Ponatinib Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Ponatinib Consumption (2017-2022)
-
10.5.2 Colombia Ponatinib Consumption (2017-2022)
-
10.5.3 Chile Ponatinib Consumption (2017-2022)
-
10.5.4 Argentina Ponatinib Consumption (2017-2022)
-
10.5.5 Venezuela Ponatinib Consumption (2017-2022)
-
10.5.6 Peru Ponatinib Consumption (2017-2022)
-
10.5.7 Puerto Rico Ponatinib Consumption (2017-2022)
-
10.5.8 Ecuador Ponatinib Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Ponatinib Consumption (2017-2022)
-
10.6.2 Kuwait Ponatinib Consumption (2017-2022)
-
10.6.3 Oman Ponatinib Consumption (2017-2022)
-
10.6.4 Qatar Ponatinib Consumption (2017-2022)
-
10.6.5 Saudi Arabia Ponatinib Consumption (2017-2022)
-
10.6.6 United Arab Emirates Ponatinib Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Ponatinib Consumption (2017-2022)
-
10.7.2 South Africa Ponatinib Consumption (2017-2022)
-
10.7.3 Egypt Ponatinib Consumption (2017-2022)
-
10.7.4 Algeria Ponatinib Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Ponatinib Consumption (2017-2022)
-
10.8.2 New Zealand Ponatinib Consumption (2017-2022)
11 Global Ponatinib Competitive Analysis
-
11.1 ARIAD Pharmaceuticals
-
11.1.1 ARIAD Pharmaceuticals Company Details
-
11.1.2 ARIAD Pharmaceuticals Ponatinib Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 ARIAD Pharmaceuticals Ponatinib Main Business and Markets Served
-
11.1.4 ARIAD Pharmaceuticals Ponatinib Product Portfolio
-
11.1.5 Recent Research and Development Strategies
12 Global Ponatinib Market Outlook by Types and Applications to 2028
-
12.1 Global Ponatinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 45mg Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 15mg Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Ponatinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global CML Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global ALL Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Ponatinib Market Analysis and Outlook to 2028
-
13.1 Global Ponatinib Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Ponatinib Consumption Forecast (2022-2028)
-
13.2.2 Canada Ponatinib Consumption Forecast (2022-2028)
-
13.2.3 Mexico Ponatinib Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Ponatinib Consumption Forecast (2022-2028)
-
13.3.2 UK Ponatinib Consumption Forecast (2022-2028)
-
13.3.3 Spain Ponatinib Consumption Forecast (2022-2028)
-
13.3.4 Belgium Ponatinib Consumption Forecast (2022-2028)
-
13.3.5 France Ponatinib Consumption Forecast (2022-2028)
-
13.3.6 Italy Ponatinib Consumption Forecast (2022-2028)
-
13.3.7 Denmark Ponatinib Consumption Forecast (2022-2028)
-
13.3.8 Finland Ponatinib Consumption Forecast (2022-2028)
-
13.3.9 Norway Ponatinib Consumption Forecast (2022-2028)
-
13.3.10 Sweden Ponatinib Consumption Forecast (2022-2028)
-
13.3.11 Poland Ponatinib Consumption Forecast (2022-2028)
-
13.3.12 Russia Ponatinib Consumption Forecast (2022-2028)
-
13.3.13 Turkey Ponatinib Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Ponatinib Consumption Forecast (2022-2028)
-
13.4.2 Japan Ponatinib Consumption Forecast (2022-2028)
-
13.4.3 India Ponatinib Consumption Forecast (2022-2028)
-
13.4.4 South Korea Ponatinib Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Ponatinib Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Ponatinib Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Ponatinib Consumption Forecast (2022-2028)
-
13.4.8 Thailand Ponatinib Consumption Forecast (2022-2028)
-
13.4.9 Singapore Ponatinib Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Ponatinib Consumption Forecast (2022-2028)
-
13.4.11 Philippines Ponatinib Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Ponatinib Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Ponatinib Consumption Forecast (2022-2028)
-
13.5.2 Colombia Ponatinib Consumption Forecast (2022-2028)
-
13.5.3 Chile Ponatinib Consumption Forecast (2022-2028)
-
13.5.4 Argentina Ponatinib Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Ponatinib Consumption Forecast (2022-2028)
-
13.5.6 Peru Ponatinib Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Ponatinib Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Ponatinib Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Ponatinib Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Ponatinib Consumption Forecast (2022-2028)
-
13.6.3 Oman Ponatinib Consumption Forecast (2022-2028)
-
13.6.4 Qatar Ponatinib Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Ponatinib Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Ponatinib Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Ponatinib Consumption Forecast (2022-2028)
-
13.7.2 South Africa Ponatinib Consumption Forecast (2022-2028)
-
13.7.3 Egypt Ponatinib Consumption Forecast (2022-2028)
-
13.7.4 Algeria Ponatinib Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Ponatinib Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Ponatinib Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Ponatinib
-
Figure of Ponatinib Picture
-
Table Global Ponatinib Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Ponatinib Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 45mg Consumption and Growth Rate (2017-2022)
-
Figure Global 15mg Consumption and Growth Rate (2017-2022)
-
Figure Global CML Consumption and Growth Rate (2017-2022)
-
Figure Global ALL Consumption and Growth Rate (2017-2022)
-
Figure Global Ponatinib Consumption by Country (2017-2022)
-
Table North America Ponatinib Consumption by Country (2017-2022)
-
Figure United States Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Canada Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Mexico Ponatinib Consumption and Growth Rate (2017-2022)
-
Table Europe Ponatinib Consumption by Country (2017-2022)
-
Figure Germany Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure UK Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Spain Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Belgium Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure France Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Italy Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Denmark Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Finland Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Norway Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Sweden Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Poland Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Russia Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Turkey Ponatinib Consumption and Growth Rate (2017-2022)
-
Table APAC Ponatinib Consumption by Country (2017-2022)
-
Figure China Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure India Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Thailand Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Singapore Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Philippines Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Ponatinib Consumption and Growth Rate (2017-2022)
-
Table South America Ponatinib Consumption by Country (2017-2022)
-
Figure Brazil Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Colombia Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Chile Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Argentina Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Peru Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Ponatinib Consumption and Growth Rate (2017-2022)
-
Table GCC Ponatinib Consumption by Country (2017-2022)
-
Figure Bahrain Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Oman Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Qatar Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Ponatinib Consumption and Growth Rate (2017-2022)
-
Table Africa Ponatinib Consumption by Country (2017-2022)
-
Figure Nigeria Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure South Africa Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Egypt Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure Algeria Ponatinib Consumption and Growth Rate (2017-2022)
-
Table Oceania Ponatinib Consumption by Country (2017-2022)
-
Figure Australia Ponatinib Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Ponatinib Consumption and Growth Rate (2017-2022)
-
Table ARIAD Pharmaceuticals Company Details
-
Table ARIAD Pharmaceuticals Ponatinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table ARIAD Pharmaceuticals Ponatinib Main Business and Markets Served
-
Table ARIAD Pharmaceuticals Ponatinib Product Portfolio
-
Figure Global 45mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 15mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CML Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALL Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ponatinib Consumption Forecast by Country (2022-2028)
-
Table North America Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure United States Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure Germany Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure China Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure Brazil Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Ponatinib Consumption Forecast by Country (2022-2028)
-
Figure Australia Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Ponatinib Consumption Forecast and Growth Rate (2022-2028)
-
